What questions should I ask about a MDS clinical trial

Questions to Ask About an MDS Clinical Trial

Great question—participating in a clinical trial can be an important treatment option for MDS patients. Here are the key questions you should ask your healthcare team to help you make an informed decision:

ABOUT THE TRIAL ITSELF

1. What is this trial testing, and how does it work?

• Ask for a clear explanation of the experimental treatment or approach
• Understand whether it's testing a new drug, a new combination of existing drugs, or a different treatment strategy
• According to NCCN Guidelines for MDS, clinical trials are recommended options for patients with disease progression or those who don't respond to standard treatments

2. What stage is this trial in?

• Phase 1 trials test safety and dosage in small groups
• Phase 2 trials test effectiveness and side effects
• Phase 3 trials compare the new treatment to standard treatment
• Each stage has different risk-benefit profiles

3. How does this trial compare to my standard treatment options?

• Ask your doctor to explain how the experimental approach differs from established MDS treatments (like hypomethylating agents such as azacitidine or decitabine, lenalidomide, or imetelstat)
• Understand the potential advantages and disadvantages

ABOUT YOUR SPECIFIC SITUATION

4. Why does my doctor think this trial is appropriate for me?

• Ask how your specific MDS characteristics (risk category, mutations, cytogenetics) make you a good candidate
• According to NCCN Guidelines, treatment decisions depend on factors like IPSS-R risk score, whether you have del(5q), SF3B1 mutations, or other genetic findings
• Understand how your individual case fits the trial's requirements

5. What are the eligibility requirements, and do I meet all of them?

• Ask about age, disease stage, organ function, and other medical conditions that might affect participation
• Clarify any requirements about prior treatments you must or cannot have had

ABOUT POTENTIAL BENEFITS AND RISKS

6. What are the potential benefits of this trial?

• Ask about response rates (how many patients improved) and what "improvement" means
• Understand realistic expectations—not all trials show benefit for all patients
• Ask if there's any chance the trial drug could help your specific MDS mutations or characteristics

7. What are the known and potential side effects?

• Request a detailed list of side effects seen in earlier trial phases
• Ask which side effects are most common and which are most serious
• Understand how side effects would be managed
• Ask about long-term effects, if known

8. What happens if the treatment isn't working or I experience serious side effects?

• Ask about stopping rules—when would you be removed from the trial?
• Understand your options if you need to exit the trial
• Ask if you can switch to other treatments

ABOUT LOGISTICS AND COMMITMENT

9. What does participation involve?

• How often will you need to visit the clinic?
• How long is the trial (weeks, months, years)?
• What tests and procedures are required?
• Will you need to stay overnight or travel?
• How much time commitment is realistic?

10. What are the costs, and what's covered?

• Ask if the experimental drug is provided free
• Clarify which visits, tests, and procedures are covered by the trial
• Understand your financial responsibility
• Ask about travel or accommodation assistance if needed

ABOUT MONITORING AND RESULTS

11. How will my response to treatment be measured?

• Ask what tests will be done (blood counts, bone marrow biopsies, genetic testing)
• Understand how often you'll be evaluated
• Ask how "response" is defined in this trial (according to NCCN Guidelines, response is typically evaluated using International Working Group criteria)

12. Will I have access to my results, and when?

• Ask when you'll know if the treatment is working
• Understand how results will be communicated to you
• Ask if you can access your data and trial results

13. What happens after the trial ends?

• Will you be able to continue the experimental treatment if it's working?
• What's the plan for ongoing care?
• How will you transition back to standard care if needed?

ABOUT YOUR RIGHTS AND PROTECTIONS

14. What are my rights as a trial participant?

• Ask about the informed consent process—you should receive detailed written information
• Understand that you can withdraw from the trial at any time without affecting your regular care
• Ask about protections for your privacy and data
• Clarify who to contact with questions or concerns

15. Is there an independent review board (IRB) overseeing this trial?

• This ensures the trial meets ethical and safety standards
• Ask how safety is being monitored

QUESTIONS SPECIFIC TO MDS GENETICS

16. Does this trial target my specific MDS mutations?

• If you have mutations like TP53, ASXL1, RUNX1, or others, ask if the trial specifically addresses these
• According to NCCN Guidelines, certain mutations (like IDH1 or IDH2) may be treated with targeted drugs like ivosidenib or enasidenib
• Ask if the trial is designed for your mutation profile

17. How does my IPSS-R risk score affect my eligibility and potential benefit?

• NCCN Guidelines emphasize that risk stratification is crucial for treatment decisions
• Ask how your risk category influences the trial's recommendations

BEFORE YOU DECIDE

18. Can I have time to think about this?

• Ask for written information about the trial
• Request the informed consent document to review carefully
• Ask if you can discuss it with family or a second opinion

19. Can I speak with other patients in this trial?

• Some trials allow you to connect with other participants
• This can provide real-world perspective on the experience

20. What would my doctor recommend if I weren't in a trial?

• This helps you understand how the trial compares to your best standard treatment option

---

KEY TAKEAWAY

According to NCCN Guidelines for MDS, clinical trials are particularly valuable options for patients with disease progression, those who don't respond to standard treatments, or those with specific genetic features that might benefit from targeted approaches. The goal is to find the right balance between potential benefit and acceptable risk for YOUR specific situation.

Take your time with this decision. Ask for written materials, request clarification on anything you don't understand, and don't hesitate to ask your doctor the same question multiple times if needed. Your healthcare team should be able to explain why they think this particular trial is right for you.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.